127 filings
Page 3 of 7
8-K
j5px5x4gs4ijih
8 Jun 22
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
0apl95ploiaj
12 May 22
Panbela Provides Business Update and Reports Q1 2022 Financial Results
4:07pm
8-K
eyg8xm1f g4spuuju
24 Mar 22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
4:06pm
8-K
0ynpsy9fkphpe
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
j1sn5mqam4zcobqg tl
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
8-K
jio6r
11 Aug 21
Panbela Provides Business Update and Reports Q2 2021 Financial Results
4:13pm
8-K
8ne2k9jw
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
5gb3h694mk2jhred
21 Jun 21
Regulation FD Disclosure
8:00am
8-K
icw94zsitp294h
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
5rp56
4 Jun 21
Regulation FD Disclosure
9:16am
8-K
p5znrtr1dor0p5x9q
26 May 21
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
8:03am
8-K
bddnmk fb4qz6ujlz4l
12 May 21
Panbela Provides Business Update and Reports Q1 2021 Financial Results
4:11pm
8-K
398x2t3
15 Apr 21
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
8:05am
8-K
6c43a9ke9 m5thgnwhb
25 Mar 21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
12:00am
8-K
0d25pfipaka 5kx
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
wfz3j9
8 Dec 20
Regulation FD Disclosure
8:01am
8-K
zysdqcthpd7 ea
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
2kno1i2m0g7ff3
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm
8-K
getj78ajd4t lll2a
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
bkt70ncwpsbwnsqadnyb
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm